INN Riamilovir
Dosage form: capsules, 250 mg.
Pharmacotherapeutic group: antiviral medicine.
Indications and usage
– as part of complex therapy for influenza and other acute respiratory viral infections in adult patients.
– for the prevention of COVID-19 infection in adults living with a person with symptomatic manifestations of confirmed COVID-19 infection
Release form: 10 capsules in a blister pack.
Instructions
Detailed information about drug studies, scientific publications and recommendations of the Ministry of Health of the Russian Federation can be found on the official website www.triazavirin.ru
